Affordable Access

Publisher Website

UbcH10 is overexpressed in malignant breast carcinomas

Authors
Journal
European Journal of Cancer
0959-8049
Publisher
Elsevier
Publication Date
Volume
43
Issue
18
Identifiers
DOI: 10.1016/j.ejca.2007.09.003
Keywords
  • Ubch10
  • Erbb2
  • Breast
  • Carcinomas
  • Tissue Micro-Array
  • Immunohistochemistry
Disciplines
  • Biology
  • Chemistry
  • Medicine

Abstract

Abstract Our group has recently demonstrated the overexpression of the UbcH10 gene in undifferentiated thyroid carcinomas. Subsequently, a clear correlation between UbcH10 overexpression and a reduced survival in ovarian carcinoma patients has been described indicating UbcH10 as a valid prognostic marker in this neoplastic disease. Here we have extended the analysis of the UbcH10 expression to neoplastic breast diseases. We demonstrated, by tissue micro-arrays immunohistochemical studies, a significant difference ( p = 0.0001) in the mean percentage of UbcH10 stained cells between benign (0.22%) and malignant (11.01%) neoplastic lesions. High UbcH10 expression was associated with intense Ki-67 staining ( p = 0.015) and ErbB2 positivity ( p = 0.092). The suppression of the ErbB2 expression in breast carcinoma cell lines induces a reduction of UbcH10 level. Consistently, the inhibition of breast carcinoma cell growth was achieved following the block of UbcH10 protein synthesis by RNA interference. Therefore, these results suggest the perspective of a therapy of aggressive breast carcinomas based on the suppression of the UbcH10 function.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

UbcH10 is overexpressed in malignant breast carcin...

on European Journal of Cancer December 2007

UbcH10 overexpression may represent a marker of an...

on British Journal of Cancer Feb 08, 2005

UbcH10 overexpression may represent a marker of an...

on British Journal of Cancer Aug 22, 2005
More articles like this..